Krishna Institute of Medical Sciences Ltd promoters Bhaskara Rao Bollineni and Bollineni Seenaiah Naidu have pledged 2,80,08,979 equity shares, representing 6.66% of the company's total share capital. The pledge was executed in favour of Catalyst Trusteeship Limited, acting as the Debenture Trustee for debenture holders.

The transaction was disclosed pursuant to Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The date of acquisition of the encumbrance was recorded as September 18, 2026. Catalyst Trusteeship Limited filed the disclosure with both the National Stock Exchange of India and BSE Limited on September 22, 2026.

Pledge Details and Shareholding

The pledged shares constitute a significant portion of the promoter group's holding, serving as security for debentures issued by the company. The acquirer in this context is the Debenture Trustee, which does not belong to the Promoter or Promoter group category but holds the shares in a fiduciary capacity.

Regulatory Compliance

The disclosure confirms that prior to this acquisition, the acquirer held no voting rights or encumbered shares in the target company. Following the pledge, the total holding of the acquirer along with Persons Acting in Concert remains at 2,80,08,979 shares, all classified under encumbrance. The mode of acquisition is explicitly stated as a pledge of equity shares rather than a transfer of ownership or voting rights.

The total diluted share/voting capital of the company remains unchanged at ₹84,00,12,968, comprising 42,00,06,484 equity shares with a face value of ₹2 each. This indicates that the pledge does not alter the capital structure of the company, only the ownership status of specific promoter-held shares until the debt obligation is met.

Krishna Institute of Medical Sciences Limited will host an analyst and institutional investor meeting on September 21, 2026. The event is scheduled as part of the J.P. Morgan India Conference in Mumbai.

The company disclosed the schedule pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is classified as a group session.

Meeting Details

The engagement aims to provide updates to investors without sharing unpublished price-sensitive information. The schedule remains subject to change based on exigencies.

Nagajanthi J.R., Company Secretary and Compliance Officer, signed the disclosure filed with the Bombay Stock Exchange and National Stock Exchange.